GlassScriptPhysician profile
Ryan M Casserly
NPI 1114344025
$23,095.25
in general payments reported to CMS, 2019-2025
18 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.88 · 2020: $44.33 · 2021: $351 · 2022: $400 · 2023: $642 · 2024: $5,224 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $3,790 · Travel and Lodging: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,300.00 |
| Food and Beverage | $3,789.84 |
| Travel and Lodging | $1,127.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $19,392.21 | 2022-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Genzyme Corporation | $877.28 | 2023-2025 | |
| Glaxosmithkline, LLC. | $449.26 | 2022-2025 | Nucala |
| Med-El Corporation | $447.09 | 2022-2024 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Advanced Bionics, LLC | $426.39 | 2019-2022 | |
| Pfizer INC. | $307.96 | 2023-2025 | |
| Stryker Corporation | $268.38 | 2024-2025 | Focess Hd Wireless Camera, Scopis Ent, Focess |
| Abbvie INC. | $168.14 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $161.28 | 2021 | |
| Inspire Medical Systems, INC. | $153.21 | 2024-2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $108.51 | 2022 | |
| Integra Lifesciences Corporation | $94.69 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Teva Pharmaceuticals USA, INC. | $55.14 | 2023-2024 | Austedo Xr, Ajovy |
| Optinose US, INC. | $47.40 | 2024-2025 | |
| Intersect Ent, INC. | $44.33 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $32.97 | 2023 | Matrixmandible, Matrixmidface |
| Ethicon US, LLC | $32.68 | 2025 | Harmonic, Smartablatetm System Rf Generator |
| Regeneron Healthcare Solutions, INC. | $28.33 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Casserly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.